1-Ethyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V)

Catalog No. :
ACPFSG712
CAS No. :
155371-19-0
Molecular Formula :
C6H11F6N2P
Molecular Weight :
256.13

IUPAC Name:1-ethyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V)

1-Ethyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$69.00Login to see priceIn stockInquiry
500g97%$295.00Login to see priceIn stockInquiry
1000g97%$472.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Ethyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V)
IUPAC Name1-ethyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V)
MDL No.MFCD00216703
Molecular FormulaC6H11F6N2P
Molecular Weight256.13
SMILESC[N+]1=CN(CC)C=C1.F[P-](F)(F)(F)(F)F
InChI KeyDPDAKOVGQUGTHH-UHFFFAOYSA-N
SynonymEMIMPF6 | AC1323 | EMIMPF6 | DPDAKOVGQUGTHH-UHFFFAOYSA-N | 1-ethyl-3-methylimidazolium hexafluorophosphate [for molten salt] | FT-0735227 | SCHEMBL19612086 | 1-Ethyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V) | DTXCID1027897 | 1-Ethyl-3-methyl-1H-i
CAS No.155371-19-0
PubChem CID2758873

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACPFSG712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAWNX395 route compound structure diagram
    ACAWNX39565039-09-0 In Stock
  2. Then
  3. ACPFSG712 route product structure diagram
    ACPFSG712155371-19-0 In Stock
Inquiry

2. ACPFSG712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRTPQ397 route compound structure diagram
    ACRTPQ3977098-07-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPFSG712 route product structure diagram
    ACPFSG712155371-19-0 In Stock
Inquiry

Comments (0)